Nothing Special   »   [go: up one dir, main page]

IT1154024B - Derivati pridinici e procedimento per la loro produzione - Google Patents

Derivati pridinici e procedimento per la loro produzione

Info

Publication number
IT1154024B
IT1154024B IT23375/82A IT2337582A IT1154024B IT 1154024 B IT1154024 B IT 1154024B IT 23375/82 A IT23375/82 A IT 23375/82A IT 2337582 A IT2337582 A IT 2337582A IT 1154024 B IT1154024 B IT 1154024B
Authority
IT
Italy
Prior art keywords
pridinical
derivatives
procedure
production
lopyridines
Prior art date
Application number
IT23375/82A
Other languages
English (en)
Other versions
IT8223375A0 (it
Inventor
Giorgio Winters
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of IT8223375A0 publication Critical patent/IT8223375A0/it
Priority to IT23375/82A priority Critical patent/IT1154024B/it
Priority to GR72382A priority patent/GR78987B/el
Priority to AT83108942T priority patent/ATE63913T1/de
Priority to EP83108942A priority patent/EP0104522B1/en
Priority to DE8383108942T priority patent/DE3382299D1/de
Priority to US06/533,909 priority patent/US4612318A/en
Priority to PT77370A priority patent/PT77370B/pt
Priority to ES83525786A priority patent/ES525786A0/es
Priority to CA000437174A priority patent/CA1248532A/en
Priority to JP58176193A priority patent/JPS5989679A/ja
Application granted granted Critical
Publication of IT1154024B publication Critical patent/IT1154024B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IT23375/82A 1982-09-22 1982-09-22 Derivati pridinici e procedimento per la loro produzione IT1154024B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT23375/82A IT1154024B (it) 1982-09-22 1982-09-22 Derivati pridinici e procedimento per la loro produzione
GR72382A GR78987B (it) 1982-09-22 1983-09-05
DE8383108942T DE3382299D1 (de) 1982-09-22 1983-09-10 Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung.
EP83108942A EP0104522B1 (en) 1982-09-22 1983-09-10 New pyrazolo(3,4-b)pyridine derivatives and process for producing them
AT83108942T ATE63913T1 (de) 1982-09-22 1983-09-10 Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung.
US06/533,909 US4612318A (en) 1982-09-22 1983-09-19 CNS-depressant and analgesic tricyclo-[pyrazolo-[3,4-6]-pyridine] derivatives and pharmaceutical compositions thereof
PT77370A PT77370B (en) 1982-09-22 1983-09-21 Process for preparing new pyrazolo <3,4-b> piridine derivatives and pharmaceutical preparations containing the same
ES83525786A ES525786A0 (es) 1982-09-22 1983-09-21 Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
CA000437174A CA1248532A (en) 1982-09-22 1983-09-21 Pyrazolo¬3,4-b|pyridine derivatives and process for producing them
JP58176193A JPS5989679A (ja) 1982-09-22 1983-09-22 ピラゾロ〔3,4−b〕ピリジン誘導体類およびそれらの製造法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23375/82A IT1154024B (it) 1982-09-22 1982-09-22 Derivati pridinici e procedimento per la loro produzione

Publications (2)

Publication Number Publication Date
IT8223375A0 IT8223375A0 (it) 1982-09-22
IT1154024B true IT1154024B (it) 1987-01-21

Family

ID=11206534

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23375/82A IT1154024B (it) 1982-09-22 1982-09-22 Derivati pridinici e procedimento per la loro produzione

Country Status (10)

Country Link
US (1) US4612318A (it)
EP (1) EP0104522B1 (it)
JP (1) JPS5989679A (it)
AT (1) ATE63913T1 (it)
CA (1) CA1248532A (it)
DE (1) DE3382299D1 (it)
ES (1) ES525786A0 (it)
GR (1) GR78987B (it)
IT (1) IT1154024B (it)
PT (1) PT77370B (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ208555A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (3-amino-1h-pyrazol-4-yl)-arylmethanone derivatives
US4751226A (en) * 1985-09-12 1988-06-14 Fujisawa Pharmaceutical Co., Ltd. Pyrazoloisoquinoline derivatives, plant growth regulating compositions, and method of use therefor
JPH0615542B2 (ja) * 1986-07-22 1994-03-02 吉富製薬株式会社 ピラゾロピリジン化合物
WO1989003385A1 (en) * 1987-10-13 1989-04-20 Yoshitomi Pharmaceutical Industries, Ltd. Fused pyrazole compounds, process for their preparation, and their medicinal use
TW444018B (en) 1992-12-17 2001-07-01 Pfizer Pyrazolopyrimidines
KR100235277B1 (ko) * 1994-06-16 1999-12-15 디. 제이. 우드, 스피겔 알렌 제이 피라졸로- 및 피롤로-피리딘
WO2001098301A1 (fr) * 2000-06-20 2001-12-27 Japan Tobacco Inc. Composes de pyrazolopyridine et utilisation de ces derniers en tant que medicaments
US20040235794A1 (en) * 2001-09-04 2004-11-25 Shinji Nakade Remedies for respiratory diseases comprising sphingosine-1-phosphate receptor controller
EP2508204B1 (en) * 2002-06-26 2014-09-24 Ono Pharmaceutical Co., Ltd. Remedies for diseases caused by vascular contraction or dilation
CA2557575A1 (en) * 2004-02-27 2005-09-15 F. Hoffmann-La Roche Ag Fused derivatives of pyrazole
RU2006134022A (ru) 2004-02-27 2008-04-10 Ф.Хоффманн-Ля Рош Аг (Ch) Производные индазола и содержащие их фармацевтические композиции
WO2005085248A1 (en) 2004-02-27 2005-09-15 F.Hoffmann-La Roche Ag Heteroaryl-fused pyrazolo derivatives
KR101011956B1 (ko) 2005-08-25 2011-01-31 에프. 호프만-라 로슈 아게 P38 mαp 키나아제 저해제 및 이의 사용 방법
JP5242419B2 (ja) 2006-02-15 2013-07-24 アボット・ラボラトリーズ ピラゾロキノロン類は強力なparp阻害薬である
CA2748276A1 (en) 2008-12-30 2010-07-08 Arqule, Inc. Substituted pyrazolo [3, 4-b] pyridine compounds
DK2379506T3 (en) 2008-12-30 2015-12-14 Arqule Inc Substituted 5,6-dihydro-6-phenylbenzo [f] isoquinolin-2-amine compounds
WO2011159864A1 (en) * 2010-06-17 2011-12-22 Bracco Imaging S.P.A. Jte013 analogs and methods of making and using same
RU2495039C1 (ru) * 2012-07-31 2013-10-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Пермский государственный национальный исследовательский университет" МЕТИЛ 3-МЕТИЛ-5-[2-(4-АРИЛАМИНО)-2-ОКСОАЦЕТИЛ]-1,6-ДИФЕНИЛ-1Н-ПИРАЗОЛО[3,4-b]ПИРИДИН-4-КАРБОКСИЛАТЫ И МЕТИЛ 3-МЕТИЛ-5-[2-(4-АРИЛАМИНО)-2-ОКСОАЦЕТИЛ]-6-СТИРИЛ-1-ФЕНИЛ-1Н-ПИРАЗОЛО[3,4-b]ПИРИДИН-4-КАРБОКСИЛАТЫ И СПОСОБ ИХ ПОЛУЧЕНИЯ
EP4001278A1 (en) * 2017-08-23 2022-05-25 Sprint Bioscience AB Azaindolylpyridone and diazaindolylpyridone compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3403158A (en) * 1966-03-11 1968-09-24 Upjohn Co 1h-pyrazolo[3, 4-b]pyridines
US3681368A (en) * 1970-10-15 1972-08-01 Abbott Lab Pyrazolo naphthridines
BE787249A (fr) * 1971-08-05 1973-02-05 Squibb & Sons Inc Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation
US3891630A (en) * 1974-03-04 1975-06-24 Abbott Lab Substituted pyrazolo{8 3,4-e{9 {8 1,4{9 thiazepines and isoxazolo{8 5,4-e{9 {8 1,4{9 thiazepines
US3903096A (en) * 1974-03-29 1975-09-02 Squibb & Sons Inc New derivatives of sulfonyl-, sulfinyl- and sulfenyl-1H-pyrazolo {8 3,4-b{9 -pyridines
EP0005745B1 (en) * 1978-05-26 1982-07-14 Gruppo Lepetit S.P.A. Pyrazolo (3,4-c) and thiazolo (5,4-c) isoquinolines, methods for preparing them, these compounds for use as antiinflammatory, cns-depressant and anti-anxiety agents and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
ES8503685A1 (es) 1985-03-01
ES525786A0 (es) 1985-03-01
ATE63913T1 (de) 1991-06-15
US4612318A (en) 1986-09-16
CA1248532A (en) 1989-01-10
GR78987B (it) 1984-10-02
IT8223375A0 (it) 1982-09-22
EP0104522B1 (en) 1991-05-29
EP0104522A3 (en) 1985-06-19
EP0104522A2 (en) 1984-04-04
PT77370B (en) 1986-04-21
JPS5989679A (ja) 1984-05-23
PT77370A (en) 1983-10-01
DE3382299D1 (de) 1991-07-04

Similar Documents

Publication Publication Date Title
IT1154024B (it) Derivati pridinici e procedimento per la loro produzione
PT78751A (en) Preparation process of 2-pyrimidinyl-1-piperazine derivatives and medicines containing them
ES8502987A1 (es) Procedimiento para preparar nuevos benzo (b) tiofenos
ES8604223A1 (es) Un procedimiento para preparar derivados de purina
IT7826537A0 (it) Derivati dell&#39;acido indolacetossiacetilaminico, processo per la loro produzione eloro impiego quali medicamenti.
IT7926964A0 (it) Procedimento per la produzione di derivati dell&#39;acido fenossicarbossilico.
BE888562A (fr) Procede de production d&#39;une preparation enzymatique de fructosyl-transferase,
ES526922A0 (es) Un procedimiento para producir derivados de antraciclina
IT8025223A0 (it) Procedimento per la produzione di derivati dell&#39;acido penicillanico.
AU544615B2 (en) Prostaglandin derivatives
ES8105711A1 (es) Un metodo de preparar derivados de piperidina
BG43688A3 (en) Method for preparing of dl- beta- aryl- aminoacids
BE848118A (fr) Procede de production d&#39;un compose extincteur,
IT7921809A0 (it) Metodo per la produzione di derivati dell&#39;acido 6-beta-amidino-penicillanico.
IT1129094B (it) Procedimento per la produzione della mildiomicina
JPS574985A (en) Novel imidazolyl-indeno-thiophene compound, manufacture and pharmaceutical use